开窗支架与开放手术治疗近肾腹主动脉瘤的倾向性评分匹配比较
本研究在2家三级中心连续纳入2005至2017年接受定制开窗腔内修复(FEVAR)或开放手术(OR)的复杂腹主动脉瘤患者,筛选近肾腹主动脉瘤(JRAA)并做倾向性评分匹配。匹配后FEVAR组54例、OR组103例,两组住院死亡率无统计学差异,FEVAR组术后并发症更少(14.8% vs 30.7%,P=0.033),但晚期再干预更多(11.3% vs 2.9%,P=0.047)。
要点
- 匹配后FEVAR组术后并发症14.8%,低于OR组的30.7%(P=0.033)。
- 住院死亡率FEVAR组1.9% vs OR组6.9%(P=0.483),无统计学差异。
- 晚期再干预FEVAR组11.3% vs OR组2.9%(P=0.047),FEVAR组更多。
核心结论
- FEVAR与OR治疗JRAA在住院、12个月及36个月死亡率上无统计学差异。
- FEVAR与OR相比术后总体主要并发症显著减少。
- FEVAR组晚期再干预显著更多。
研究设计与样本
- 2005至2017年在2家三级中心连续接受定制FEVAR或OR的复杂腹主动脉瘤患者,筛选JRAA为研究组,排除肾上及胸腹主动脉瘤。
- 共纳入277例JRAA患者,FEVAR组102例(36.8%)、OR组175例(63.2%)。
- 采用倾向性评分匹配使两组可比,匹配后FEVAR组54例(52.9%)、OR组103例(58.9%)进入分析。
主要发现
- 住院死亡率FEVAR组1.9%(n=1)vs OR组6.9%(n=7),P=0.483。
- 术后并发症FEVAR组14.8% vs OR组30.7%,P=0.033。
- 平均随访FEVAR组42.1个月、OR组40个月。
- 12个月总死亡率FEVAR组11.5% vs OR组9.1%(P=0.691);36个月FEVAR组24.5% vs OR组11.6%(P=0.067)。
- 晚期再干预FEVAR组11.3% vs OR组2.9%(P=0.047);免于再干预率12个月FEVAR组86% vs OR组90%(P=0.560),36个月FEVAR组86% vs OR组88.4%(P=0.690)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to compare postoperative morbi-mortality and medium-term follow-up of fenestrated stent grafting and open repair (OR) for patients with juxtarenal aortic aneurysms (JRAAs). METHODS: All consecutive patients who underwent custom-made fenestrated endovascular aortic repair (FEVAR) or OR for complex abdominal aortic aneurysm between 2005 and 2017 in 2 tertiary centers were scrutinized. Patients with JRAA constituted the study group. Suprarenal and thoracoabdominal aortic aneurysms were excluded. The groups were made comparable through the use of a propensity score matching. RESULTS: 277 patients with JRAAs were included, 102 (36.8%) in the FEVAR group and 175 (63.2%) in the OR group, respectively. After propensity score matching, 54 FEVAR patients (52.9%) and 103 OR patients (58.9%) were included for analysis. In-hospital mortality rates were 1.9% (n = 1) in the FEVAR group versus 6.9% (n = 7) in the OR group (P = 0.483). Postoperative complications were less common in the FEVAR group (14.8% vs. 30.7%; P = 0.033). Mean follow-up was 42.1 months in the FEVAR group and 40 months in the OR group. Overall mortality rates at 12 and 36 months were 11.5% and 24.5% in the FEVAR group versus 9.1 % (P = 0.691) and 11.6% (P = 0.067) in the OR group. Late reinterventions were more frequent in the FEVAR group (11.3% vs. 2.9%; P = 0.047). However, freedom from reintervention rates were not significantly different at 12 months (FEVAR: 86% vs. OR: 90%; P = 0.560) and 36 months (FEVAR: 86% vs. OR: 88.4%, P = 0.690). In the FEVAR group, persistent endoleak during follow-up was identified in 11.3% of cases. CONCLUSIONS: In the present study, there was no statistical difference in terms of mortality in-hospital at 12 or 36 months between FEVAR and OR groups for JRAA. FEVAR for JRAA was associated with a significant reduction of overall postoperative major complications compared with OR. There were significantly more late reinterventions in the FEVAR group.
引用
- Bizos A, Hostalrich A, Chaufour X, et al. Comparison of Fenestrated Stentgrafts and Open Repair for Juxtarenal Aortic Aneurysms Using a Propensity Score Matching. Ann Vasc Surg. 2023. PMID: 37270093. doi:10.1016/j.avsg.2023.05.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。